WHO-aligned artemisinin-based combinations (ACTs), severe-malaria injectables and pediatric formulations for endemic markets.
Malaria still claims over 600,000 lives every year, most of them children under five in sub-Saharan Africa. Artemisine Medicines Technology manufactures a complete antimalarial portfolio aligned with WHO treatment guidelines — from first-line artemisinin-based combination therapies (ACTs) to life-saving injectables for severe malaria.
Our artemisinin line includes artemether-lumefantrine tablets (the world's most widely used ACT), artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine combinations. For severe and complicated malaria we supply artesunate powder for injection, artemether injection and quinine dihydrochloride injection — the products WHO recommends for referral-level care.
Pediatric malaria needs child-friendly formulations: our artemether and artesunate oral suspensions and artesunate suppositories cover infants and children who cannot swallow tablets. Every batch is produced in China-GMP workshops (site re-inspected and passed in 2026), released against BP / enterprise monographs and shipped with COA, COPP, DMF and CTD dossiers for national registration and tender participation.
All products are GMP manufactured and supplied with COA, COPP, DMF and CTD dossiers. Tap any product for specifications and WHO prescribing guidance.
Tell us your target market and annual volume — our export team replies within 24 hours.
Artemether-lumefantrine tablets, artesunate-amodiaquine, dihydroartemisinin-piperaquine, artesunate-pyronaridine, sulfadoxine-pyrimethamine combinations, artesunate powder for injection, artemether injection, quinine injection, chloroquine tablets, plus pediatric oral suspensions and artesunate suppositories.
Yes. The portfolio mirrors WHO Guidelines for Malaria: ACTs as first-line for uncomplicated P. falciparum malaria, injectable artesunate as first-line for severe malaria, with dosing references from the WHO Model Formulary.
Every antimalarial ships with COA per batch, COPP, DMF and CTD-format dossiers, plus legalisation support for ministry-of-health registration and international tenders.
Artemisine Medicines